ATRC
Price
$31.50
Change
+$1.33 (+4.41%)
Updated
Jul 25 closing price
Capitalization
1.45B
3 days until earnings call
SRDX
Price
$32.05
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
397.04M
4 days until earnings call
Interact to see
Advertisement

ATRC vs SRDX

Header iconATRC vs SRDX Comparison
Open Charts ATRC vs SRDXBanner chart's image
AtriCure
Price$31.50
Change+$1.33 (+4.41%)
Volume$589.27K
Capitalization1.45B
Surmodics
Price$32.05
Change-$0.00 (-0.00%)
Volume$148.42K
Capitalization397.04M
ATRC vs SRDX Comparison Chart in %
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. SRDX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and SRDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ATRC: $31.50 vs. SRDX: $36.00)
Brand notoriety: ATRC and SRDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 134% vs. SRDX: 174%
Market capitalization -- ATRC: $1.45B vs. SRDX: $397.04M
ATRC [@Medical Specialties] is valued at $1.45B. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRC and SRDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 6 TA indicator(s) are bullish while SRDX’s TA Score has 3 bullish TA indicator(s).

  • ATRC’s TA Score: 6 bullish, 3 bearish.
  • SRDX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than SRDX.

Price Growth

ATRC (@Medical Specialties) experienced а +7.66% price change this week, while SRDX (@Medical Specialties) price change was +19.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

ATRC is expected to report earnings on Jul 29, 2025.

SRDX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than SRDX($397M). SRDX has higher P/E ratio than ATRC: SRDX (71.51) vs ATRC (36.76). ATRC YTD gains are higher at: 3.076 vs. SRDX (-9.091). SRDX has higher annual earnings (EBITDA): 22.1M vs. ATRC (-8.11M). ATRC has more cash in the bank: 137M vs. SRDX (35.2M). SRDX has less debt than ATRC: SRDX (33.9M) vs ATRC (74.5M). ATRC has higher revenues than SRDX: ATRC (399M) vs SRDX (138M).
ATRCSRDXATRC / SRDX
Capitalization1.45B397M365%
EBITDA-8.11M22.1M-37%
Gain YTD3.076-9.091-34%
P/E Ratio36.7671.5151%
Revenue399M138M289%
Total Cash137M35.2M389%
Total Debt74.5M33.9M220%
FUNDAMENTALS RATINGS
ATRC vs SRDX: Fundamental Ratings
ATRC
SRDX
OUTLOOK RATING
1..100
5675
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
6357
P/E GROWTH RATING
1..100
9793
SEASONALITY SCORE
1..100
n/a21

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRC's Valuation (69) in the Medical Specialties industry is in the same range as SRDX (92). This means that ATRC’s stock grew similarly to SRDX’s over the last 12 months.

ATRC's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that ATRC’s stock grew similarly to SRDX’s over the last 12 months.

ATRC's SMR Rating (93) in the Medical Specialties industry is in the same range as SRDX (93). This means that ATRC’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (57) in the Medical Specialties industry is in the same range as ATRC (63). This means that SRDX’s stock grew similarly to ATRC’s over the last 12 months.

SRDX's P/E Growth Rating (93) in the Medical Specialties industry is in the same range as ATRC (97). This means that SRDX’s stock grew similarly to ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCSRDX
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHMUF11.315.49
+94.46%
Shimizu Corp.
DTEGF37.640.38
+1.02%
Deutsche Telekom AG
LPSIF0.08N/A
N/A
Legend Power Systems Inc.
TPGVF0.16N/A
N/A
Top Glove Corp.
VLDX0.47-0.01
-2.08%
Velo3D, Inc.

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with SIBN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+4.41%
SIBN - ATRC
44%
Loosely correlated
-0.63%
IRMD - ATRC
43%
Loosely correlated
-0.49%
CERS - ATRC
42%
Loosely correlated
+2.21%
KIDS - ATRC
38%
Loosely correlated
-0.04%
TMCI - ATRC
38%
Loosely correlated
-1.55%
More

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+12.32%
PXMBF - SRDX
41%
Loosely correlated
N/A
BLCO - SRDX
30%
Poorly correlated
+2.51%
BDX - SRDX
30%
Poorly correlated
+0.92%
ATRC - SRDX
30%
Poorly correlated
+4.41%
TFX - SRDX
29%
Poorly correlated
+0.85%
More